FDA reform: incremental approach urged by Rep. Fox in a Dec. 22 letter.
This article was originally published in The Rose Sheet
Executive Summary
FDA REFORM SHOULD FOCUS ON CONSENSUS ISSUES FIRST, REP. FOX urged in a recent letter to the House Republican leadership. Congress "should move immediately to develop a bipartisan consensus on those [FDA reform] changes that we can make to ease current regulatory requirements," according to the Dec. 22 letter drafted by Rep. Jon Fox (R-PA) and signed by nearly all members of the Pennsylvania House delegation. The letter was sent to Speaker Newt Gingrich (R-GA), Commerce Committee Chairman Thomas Bliley (R-VA) and Commerce/Health & Environment Subcommittee Chairman Michael Bilirakis (R-FL).